Published in Stroke on June 01, 2001
Apnea, Stroke and Incident Cardiovascular Events (ASCENT) | NCT04399200
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol (2013) 6.18
Older adults with cognitive complaints show brain atrophy similar to that of amnestic MCI. Neurology (2006) 3.72
MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment. Neurology (2007) 3.24
Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer's Association Research Roundtable Workgroup. Alzheimers Dement (2011) 3.05
Atrophy rates accelerate in amnestic mild cognitive impairment. Neurology (2007) 2.93
Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis. Lancet Neurol (2012) 2.75
Ischemic brain lesions after carotid artery stenting increase future cerebrovascular risk. J Am Coll Cardiol (2015) 2.61
The Secondary Prevention of Small Subcortical Strokes (SPS3) study. Int J Stroke (2011) 2.35
Effect of white-matter lesions on the risk of periprocedural stroke after carotid artery stenting versus endarterectomy in the International Carotid Stenting Study (ICSS): a prespecified analysis of data from a randomised trial. Lancet Neurol (2013) 2.26
Enlarged perivascular spaces are associated with cognitive function in healthy elderly men. J Neurol Neurosurg Psychiatry (2004) 2.11
Beta-amyloid burden is not associated with rates of brain atrophy. Ann Neurol (2008) 1.93
Global and regional effects of type 2 diabetes on brain tissue volumes and cerebral vasoreactivity. Diabetes Care (2007) 1.77
Association between brain imaging signs, early and late outcomes, and response to intravenous alteplase after acute ischaemic stroke in the third International Stroke Trial (IST-3): secondary analysis of a randomised controlled trial. Lancet Neurol (2015) 1.74
Cognitive functioning in orthostatic hypotension due to pure autonomic failure. Clin Auton Res (2006) 1.63
Risk vs benefit of anti-thrombotic therapy in ischaemic stroke patients with cerebral microbleeds. J Neurol (2008) 1.63
White matter hyperintensities and dynamics of postural control. Magn Reson Imaging (2009) 1.60
Severity of leukoaraiosis correlates with clinical outcome after ischemic stroke. Neurology (2009) 1.56
Automated detection of brain atrophy patterns based on MRI for the prediction of Alzheimer's disease. Neuroimage (2009) 1.55
Cerebral blood flow velocity and periventricular white matter hyperintensities in type 2 diabetes. Diabetes Care (2006) 1.52
In vivo detection of cerebral cortical microinfarcts with high-resolution 7T MRI. J Cereb Blood Flow Metab (2012) 1.49
Diffusion indices on magnetic resonance imaging and neuropsychological performance in amnestic mild cognitive impairment. J Neurol Neurosurg Psychiatry (2006) 1.49
Triple dissociation of attention networks in stroke according to lesion location. Neurology (2013) 1.46
Plasma homocysteine and severe white matter disease. Neurol Sci (2007) 1.45
Age-specific association of migraine with cryptogenic TIA and stroke: Population-based study. Neurology (2015) 1.42
Carotid Anatomy Does Not Predict the Risk of New Ischaemic Brain Lesions on Diffusion-Weighted Imaging after Carotid Artery Stenting in the ICSS-MRI Substudy. Eur J Vasc Endovasc Surg (2015) 1.41
The brain in myotonic dystrophy 1 and 2: evidence for a predominant white matter disease. Brain (2011) 1.36
Medial temporal atrophy but not memory deficit predicts progression to dementia in patients with mild cognitive impairment. J Neurol Neurosurg Psychiatry (2006) 1.34
Cognitive impairment and functional outcome after stroke associated with small vessel disease. J Neurol Neurosurg Psychiatry (2004) 1.33
Enlarged perivascular spaces as a marker of underlying arteriopathy in intracerebral haemorrhage: a multicentre MRI cohort study. J Neurol Neurosurg Psychiatry (2013) 1.32
Automatic morphometry in Alzheimer's disease and mild cognitive impairment. Neuroimage (2011) 1.32
The cerebellum and emotional experience. Neuropsychologia (2006) 1.31
Disruption of the cerebral white matter network is related to slowing of information processing speed in patients with type 2 diabetes. Diabetes (2013) 1.29
Longitudinal 1H MRS changes in mild cognitive impairment and Alzheimer's disease. Neurobiol Aging (2006) 1.28
Imaging cerebral microbleeds using susceptibility weighted imaging: one step toward detecting vascular dementia. J Magn Reson Imaging (2010) 1.25
Microstructural white matter abnormalities and cognitive functioning in type 2 diabetes: a diffusion tensor imaging study. Diabetes Care (2012) 1.22
Diagnostic criteria for vascular cognitive disorders: a VASCOG statement. Alzheimer Dis Assoc Disord (2014) 1.21
Neuroimaging of mobility in aging: a targeted review. J Gerontol A Biol Sci Med Sci (2014) 1.20
Supporting evidence for using biomarkers in the diagnosis of MCI due to AD. J Neurol (2012) 1.20
Obstructive sleep apnea as a risk factor for cerebral white matter change in a middle-aged and older general population. Sleep (2013) 1.19
Principal component analysis of FDG PET in amnestic MCI. Eur J Nucl Med Mol Imaging (2008) 1.13
Longitudinal effects of lesions on functional networks after stroke. J Cereb Blood Flow Metab (2013) 1.11
Extent of white matter lesions is related to acute subcortical infarcts and predicts further stroke risk in patients with first ever ischaemic stroke. J Neurol Neurosurg Psychiatry (2005) 1.11
Brain involvement in myotonic dystrophies: neuroimaging and neuropsychological comparative study in DM1 and DM2. J Neurol (2010) 1.07
Current concepts of analysis of cerebral white matter hyperintensities on magnetic resonance imaging. Top Magn Reson Imaging (2005) 1.05
Mapping the effect of APOE epsilon4 on gray matter loss in Alzheimer's disease in vivo. Neuroimage (2009) 1.05
High-resolution ultrahigh-field MRI of stroke. Magn Reson Imaging (2005) 1.05
Brain and spine MRI features of Hunter disease: frequency, natural evolution and response to therapy. J Inherit Metab Dis (2011) 1.03
Age- and sex-specific rates of leukoaraiosis in TIA and stroke patients: population-based study. Neurology (2012) 1.00
Development of screening guidelines and clinical criteria for predementia Alzheimer's disease. The DESCRIPA Study. Neuroepidemiology (2008) 1.00
Hyperintense acute reperfusion marker on FLAIR is not associated with early haemorrhagic transformation in the elderly. Eur Radiol (2010) 0.99
Shunt-responsive parkinsonism and reversible white matter lesions in patients with idiopathic NPH. J Neurol (2008) 0.99
Post-mortem assessment in vascular dementia: advances and aspirations. BMC Med (2016) 0.98
Default Mode Network Connectivity in Stroke Patients. PLoS One (2013) 0.97
Effects of statins on the progression of cerebral white matter lesion: Post hoc analysis of the ROCAS (Regression of Cerebral Artery Stenosis) study. J Neurol (2009) 0.96
Cerebral amyloid angiopathy-related inflammation: imaging findings and clinical outcome. Neuroradiology (2014) 0.96
Brain SPECT in subtypes of mild cognitive impairment. Findings from the DESCRIPA multicenter study. J Neurol (2008) 0.95
Swirl sign in intracerebral haemorrhage: definition, prevalence, reliability and prognostic value. BMC Neurol (2012) 0.94
Whole brain N-acetylaspartate concentration is conserved throughout normal aging. Neurobiol Aging (2012) 0.93
Lacunar strokes in patients with diabetes mellitus: risk factors, infarct location, and prognosis: the secondary prevention of small subcortical strokes study. Stroke (2014) 0.93
Age-related white matter changes. J Aging Res (2011) 0.93
Clinical spectrum, underlying etiologies and radiological characteristics of cortical superficial siderosis. J Neurol (2015) 0.93
Neuroimaging tools to rate regional atrophy, subcortical cerebrovascular disease, and regional cerebral blood flow and metabolism: consensus paper of the EADC. J Neurol Neurosurg Psychiatry (2003) 0.93
Quantitative EEG Markers in Mild Cognitive Impairment: Degenerative versus Vascular Brain Impairment. Int J Alzheimers Dis (2012) 0.92
Alterations in working memory as a function of leukoaraiosis in dementia. Neuropsychologia (2006) 0.92
Impaired cognitive functions in mild traumatic brain injury patients with normal and pathologic magnetic resonance imaging. Neuroradiology (2006) 0.91
Small vessel versus large vessel vascular dementia: risk factors and MRI findings. J Neurol (2008) 0.91
MRI-visible perivascular spaces: relationship to cognition and small vessel disease MRI markers in ischaemic stroke and TIA. J Neurol Neurosurg Psychiatry (2013) 0.90
Non-locally regularized segmentation of multiple sclerosis lesion from multi-channel MRI data. Magn Reson Imaging (2014) 0.90
Isolated blood-cerebrospinal fluid barrier dysfunction: prevalence and associated diseases. J Neurol (2005) 0.89
Risk of "silent stroke" in patients older than 60 years: risk assessment and clinical perspectives. Clin Interv Aging (2010) 0.89
Neuronal and glia-related biomarkers in cerebrospinal fluid of patients with acute ischemic stroke. J Cent Nerv Syst Dis (2014) 0.89
Frontal lobe hypoperfusion and depressive symptoms in Alzheimer disease. J Psychiatry Neurosci (2008) 0.89
Quantitation, regional vulnerability, and kinetic modeling of brain glucose metabolism in mild Alzheimer's disease. Eur J Nucl Med Mol Imaging (2007) 0.89
Prevalence of stroke in Restless Legs Syndrome: Initial Results Point to the Need for More Sophisticated Studies. Open Neurol J (2010) 0.89
An algorithmic approach to structural imaging in dementia. J Neurol Neurosurg Psychiatry (2013) 0.89
Changes in cerebrospinal fluid and blood plasma levels of IGF-II and its binding proteins in Alzheimer's disease: an observational study. BMC Neurol (2014) 0.89
Increase of theta frequency is associated with reduction in regional cerebral blood flow only in subjects with mild cognitive impairment with higher upper alpha/low alpha EEG frequency power ratio. Front Behav Neurosci (2013) 0.89
Diffusion tensor tractography versus volumetric imaging in the diagnosis of behavioral variant frontotemporal dementia. PLoS One (2013) 0.88
Brain perfusion correlates of medial temporal lobe atrophy and white matter hyperintensities in mild cognitive impairment. J Neurol (2007) 0.88
Silent neurological involvement in biopsy-defined coeliac patients. Neurol Sci (2013) 0.88
Cognitive function correlates with frontal white matter apparent diffusion coefficients in patients with leukoaraiosis. J Neurol (2008) 0.87
Cerebral inflammation is an underlying mechanism of early death in Alzheimer's disease: a 13-year cause-specific multivariate mortality study. Alzheimers Res Ther (2014) 0.87
Neuroimaging characteristics in mitochondrial encephalopathies associated with the m.3243A>G MTTL1 mutation. J Neurol (2012) 0.87
The new Alzheimer's criteria in a naturalistic series of patients with mild cognitive impairment. J Neurol (2010) 0.87
Plasma β-amyloid in Alzheimer's disease and vascular disease. Sci Rep (2016) 0.86
Arterial spin labelling reveals prolonged arterial arrival time in idiopathic Parkinson's disease. Neuroimage Clin (2014) 0.86
Identifying the neural correlates of executive functions in early cerebral microangiopathy: a combined VBM and DTI study. J Cereb Blood Flow Metab (2012) 0.86
Motor dysfunction correlates with frontal white matter ischemic changes in patients with leukoaraiosis. J Aging Res (2011) 0.86
Biological markers for early detection and pharmacological treatment of Alzheimer's disease. Dialogues Clin Neurosci (2009) 0.86
Aberrant functional connectivity of default-mode network in type 2 diabetes patients. Eur Radiol (2015) 0.86
Tooth loss is associated with brain white matter change and silent infarction among adults without dementia and stroke. J Korean Med Sci (2013) 0.86
Medial temporal atrophy in early and late-onset Alzheimer's disease. Neurobiol Aging (2014) 0.85
Blood pressure after recent stroke: baseline findings from the secondary prevention of small subcortical strokes trial. Am J Hypertens (2013) 0.85
In vivo imaging of the 18-kDa translocator protein (TSPO) with [18F]FEDAA1106 and PET does not show increased binding in Alzheimer's disease patients. Eur J Nucl Med Mol Imaging (2013) 0.85
Cognitive impairment in myotonic dystrophy type 1 is associated with white matter damage. PLoS One (2014) 0.85
Lesion Explorer: a video-guided, standardized protocol for accurate and reliable MRI-derived volumetrics in Alzheimer's disease and normal elderly. J Vis Exp (2014) 0.84
Leukoaraiosis is a chronic atherosclerotic disease. ScientificWorldJournal (2012) 0.84
White matter hyperintensities segmentation: a new semi-automated method. Front Aging Neurosci (2013) 0.84
Spontaneous brain activity in type 2 diabetics revealed by amplitude of low-frequency fluctuations and its association with diabetic vascular disease: a resting-state FMRI study. PLoS One (2014) 0.84
Disrupted resting-state attentional networks in T2DM patients. Sci Rep (2015) 0.84
Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology (2005) 21.67
Consistent resting-state networks across healthy subjects. Proc Natl Acad Sci U S A (2006) 19.60
Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology (1993) 16.92
Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med (2004) 16.58
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol (1987) 8.48
Reduced resting-state brain activity in the "default network" in normal aging. Cereb Cortex (2007) 5.28
Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study. Lancet (2001) 4.55
Termination of trial of streptokinase in severe acute ischaemic stroke. MAST Study Group. Lancet (1995) 4.50
Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes. Neurology (2006) 4.38
Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry (1992) 4.16
Normal CSF ferritin levels in MS suggest against etiologic role of chronic venous insufficiency. Neurology (2010) 3.98
Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain (1997) 3.87
Tinzaparin in acute ischaemic stroke (TAIST): a randomised aspirin-controlled trial. Lancet (2001) 3.69
Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease. Arch Neurol (1999) 3.62
The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease. Neurology (1999) 3.49
Graph theoretical analysis of magnetoencephalographic functional connectivity in Alzheimer's disease. Brain (2008) 3.36
Global and local gray matter loss in mild cognitive impairment and Alzheimer's disease. Neuroimage (2004) 3.25
Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease? Mol Chem Neuropathol (1995) 3.23
A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging. J Neurol Sci (1993) 3.16
Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2. Neurology (1996) 2.94
Medial temporal lobe atrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment. J Neurol (1999) 2.92
Postwithdrawal rebound increase in T2 lesional activity in natalizumab-treated MS patients. Neurology (2007) 2.88
Cortical lesions in multiple sclerosis. Brain (1999) 2.83
Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease. Neuroepidemiology (1998) 2.83
Incident lacunes influence cognitive decline: the LADIS study. Neurology (2011) 2.81
A comprehensive study of gray matter loss in patients with Alzheimer's disease using optimized voxel-based morphometry. Neuroimage (2003) 2.67
Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann Neurol (1999) 2.61
Amnestic syndrome of the medial temporal type identifies prodromal AD: a longitudinal study. Neurology (2007) 2.61
Research criteria for subcortical vascular dementia in clinical trials. J Neural Transm Suppl (2000) 2.56
Atherosclerotic disease of the aortic arch as a risk factor for recurrent ischemic stroke. The French Study of Aortic Plaques in Stroke Group. N Engl J Med (1996) 2.55
Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline. Eur J Neurol (2007) 2.47
Global target profile of the kinase inhibitor bosutinib in primary chronic myeloid leukemia cells. Leukemia (2008) 2.44
Association of gait and balance disorders with age-related white matter changes: the LADIS study. Neurology (2008) 2.41
Medial temporal lobe atrophy predicts Alzheimer's disease in patients with minor cognitive impairment. J Neurol Neurosurg Psychiatry (2002) 2.41
Statins as immunomodulators: comparison with interferon-beta 1b in MS. Neurology (2002) 2.34
APOE and Alzheimer disease: a major gene with semi-dominant inheritance. Mol Psychiatry (2011) 2.31
Prevalence and severity of microbleeds in a memory clinic setting. Neurology (2006) 2.29
Indolent course of progressive multifocal leukoencephalopathy during natalizumab treatment in MS. Neurology (2011) 2.26
Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization. Neurosci Lett (2000) 2.25
Risk factors for progression of brain atrophy in aging: six-year follow-up of normal subjects. Neurology (2005) 2.24
EFNS guidelines for the diagnosis and management of Alzheimer's disease. Eur J Neurol (2010) 2.21
Small-vessel disease relates to poor poststroke survival in a 12-year follow-up. Neurology (2011) 2.19
Alexander disease: ventricular garlands and abnormalities of the medulla and spinal cord. Neurology (2006) 2.19
Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis. Neurology (1998) 2.17
Consensus recommendations for MS cortical lesion scoring using double inversion recovery MRI. Neurology (2011) 2.17
Postmortem verification of MS cortical lesion detection with 3D DIR. Neurology (2012) 2.16
Determinants of brain iron in multiple sclerosis: a quantitative 3T MRI study. Neurology (2011) 2.11
High total cholesterol levels in late life associated with a reduced risk of dementia. Neurology (2005) 2.07
Thrombolysis in cervical artery dissection--data from the Cervical Artery Dissection and Ischaemic Stroke Patients (CADISP) database. Eur J Neurol (2012) 2.07
Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines. J Neurol Neurosurg Psychiatry (1991) 2.05
Comparison of 7.0-T T₂*-magnetic resonance imaging of cerebral bleeds in post-mortem brain sections of Alzheimer patients with their neuropathological correlates. Cerebrovasc Dis (2011) 2.05
Early predictors of death and disability after acute cerebral ischemic event. Stroke (1995) 2.04
Regional DTI differences in multiple sclerosis patients. Neuroimage (2008) 2.03
Psoriasis: is the impairment to a patient's life cumulative? J Eur Acad Dermatol Venereol (2010) 2.01
White matter hyperintensities on MRI in the neurologically nondiseased elderly. Analysis of cohorts of consecutive subjects aged 55 to 85 years living at home. Stroke (1995) 2.01
Decreased interleukin-10 and increased interleukin-12p40 mRNA are associated with disease activity and characterize different disease stages in multiple sclerosis. Ann Neurol (1999) 1.99
Visual rating and volumetry of the medial temporal lobe on magnetic resonance imaging in dementia: a comparative study. J Neurol Neurosurg Psychiatry (2000) 1.97
Spinal cord infarction: clinical and magnetic resonance imaging findings and short term outcome. J Neurol Neurosurg Psychiatry (2004) 1.95
CSF biomarkers and medial temporal lobe atrophy predict dementia in mild cognitive impairment. Neurobiol Aging (2006) 1.91
MRI criteria for MS in patients with clinically isolated syndromes. Neurology (2010) 1.90
Diagnosis and management of Alzheimer's disease and other disorders associated with dementia. The role of neurologists in Europe. European Federation of Neurological Societies. Eur J Neurol (2000) 1.89
Hippocampal atrophy rates in Alzheimer disease: added value over whole brain volume measures. Neurology (2009) 1.88
Spontaneous MxA mRNA level predicts relapses in patients with recently diagnosed MS. Neurology (2010) 1.88
Visual assessment of medial temporal lobe atrophy on magnetic resonance imaging: interobserver reliability. J Neurol (1995) 1.87
Tau and Abeta42 in cerebrospinal fluid from healthy adults 21-93 years of age: establishment of reference values. Clin Chem (2001) 1.87
Incidence of ROP in two consecutive Swedish population based studies. Br J Ophthalmol (2002) 1.86
Histopathologic correlates of white matter changes on MRI in Alzheimer's disease and normal aging. Neurology (1995) 1.86
White matter changes in healthy elderly persons correlate with attention and speed of mental processing. Arch Neurol (1993) 1.86
Cytosolic free calcium elevation mediates the phagosome-lysosome fusion during phagocytosis in human neutrophils. J Cell Biol (1990) 1.85
Neuropsychologic correlates of MRI white matter hyperintensities: a study of 150 normal volunteers. Neurology (1993) 1.85
Heterogeneity of white matter hyperintensities in Alzheimer's disease: post-mortem quantitative MRI and neuropathology. Brain (2008) 1.84
CT and MRI rating of white matter lesions. Cerebrovasc Dis (2002) 1.83
Lipid lowering agents are associated with a slower cognitive decline in Alzheimer's disease. J Neurol Neurosurg Psychiatry (2005) 1.81